Pluronic lecithin organogel of 5-aminosalicylic acid for wound healing

Drug Development and Industrial Pharmacy
Bharat Kumar Reddy SanapalliVeera Venkata Satyanarayana Reddy Karri

Abstract

5-Aminosalicylic acid (5-ASA) is an aminosalicylate anti-inflammatory drug, which is also known as mesalazine or mesalamine. Currently employed in treating inflammatory bowel disease, ulcerative colitis, inflamed anus or rectum, and maintain remission in Crohn's disease. Evidence from the researchers highlighted its significant re-epithelization in allergic asthma, aphthous, and gastric ulcerative conditions. The objective of the study was to formulate the pluronic lecithin organogel (PLO) containing 5-ASA and evaluate its wound-healing ability in a full thickness excision wound rat model. The data obtained from in silico docking studies revealed 5-ASA is having an affinity towards the transforming growth factor-beta (TGF-β) specifically towards beta1. Among various formulations prepared (F1 to F8), F1, and F6 have shown a maximum in vitro drug release with optimum pH and viscosity. From MTT assay it was found that selected PLO formulations showed no toxicity and enhanced cell proliferation in HaCaT cell lines. In vivo wound-healing studies in albino Wistar rats has revealed that PLO accelerates wound closure and reepithelization to the statistically significant level on day 3 (p < .05) in comparison with untreated wounds. In c...Continue Reading

References

Feb 1, 1992·The British Journal of Dermatology·P M CollierP W Copeman
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A B RobertsJ H Kehrl
Aug 1, 1994·The Journal of Investigative Dermatology·J GailitR A Clark
Feb 1, 1996·Archives of Otolaryngology--head & Neck Surgery·A V NallA Kalra
Jun 1, 1996·Clinical Biochemistry·G K Reddy, C S Enwemeka
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
Mar 26, 2002·Digestive Diseases and Sciences·Javier P GisbertJosé María Pajares
Dec 22, 1951·British Medical Journal·D GILMOUR, A J SYKES
Jul 17, 2004·Evidence-based Complementary and Alternative Medicine : ECAM·Edwin L. Cooper
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Rahul Mehra, D George Wyse
Sep 17, 2005·Scandinavian Journal of Gastroenterology·Daniel C BaumgartAxel U Dignass
Mar 21, 2007·Expert Opinion on Drug Safety·Alan C Moss, Mark A Peppercorn
Nov 26, 2009·The Journal of International Medical Research·Tomaz VelnarV Smrkolj
Jan 14, 2010·Molecular Medicine·Irena PastarMarjana Tomic-Canic
Feb 9, 2010·Journal of Dental Research·S Guo, L A Dipietro
Jan 31, 2012·Journal of Thrombosis and Haemostasis : JTH·S M EvrardD M Smadja
Nov 24, 2012·BMC Complementary and Alternative Medicine·Wei-Cheng ChenI-Min Liu
Apr 13, 2013·Journal of Computer-aided Molecular Design·G Madhavi SastryWoody Sherman
Dec 4, 2013·Drug Delivery·Gehan BalataSahar Radwan
Aug 8, 2014·Pulmonary Pharmacology & Therapeutics·K Rama Satyanarayana RajuKannan Elango
Jun 9, 2017·Cellular and Molecular Gastroenterology and Hepatology·Kyoko Oh-OkaAtsuhito Nakao
Jul 19, 2017·Scientific Reports·Ya-Nan ZhaoYongjun Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved